C270-0713 Screening compound: 1-({1-[(2-chlorophenyl)methyl]piperidin-4-yl}methyl)-3-(2,5-dimethoxyphenyl)urea

C270-0713 Screening compound: 1-({1-[(2-chlorophenyl)methyl]piperidin-4-yl}methyl)-3-(2,5-dimethoxyphenyl)urea
C270-0713 Screening compound: 1-({1-[(2-chlorophenyl)methyl]piperidin-4-yl}methyl)-3-(2,5-dimethoxyphenyl)urea alternative view

Chemical Structure Depiction of ChemDiv screening compound C270-0713
1-({1-[(2-chlorophenyl)methyl]piperidin-4-yl}methyl)-3-(2,5-dimethoxyphenyl)urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C270-0713

Molecular Formula

C22H28ClN3O3 (C22 H28 ClN3 O3)

Compound Name

1-({1-[(2-chlorophenyl)methyl]piperidin-4-yl}methyl)-3-(2,5-dimethoxyphenyl)urea

IUPAC name

1-({1-[(2-chlorophenyl)methyl]piperidin-4-yl}methyl)-3-(25-dimethoxyphenyl)urea

SMILES

COc(cc1)cc(NC(NCC2CCN(Cc(cccc3)c3Cl)CC2)=O)c1OC

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

417.94

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.126

Distribution Coefficient, logD

2.489

Water Solubility, LogSw

-4.44

Polar Surface Area

52.072

Acid Dissociation Constant (pKa)

11.39

Base Dissociation Constant (pKb)

9.03

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

C270-0713 in Drug Discovery

Included in Screening Libraries

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Immune system
Targets:
  • GPCR
  • Ion Channels
  • Proteases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C270-0713 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C270-0713?
Check Price and Availability of C270-0713, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C270-0713 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C270-0713
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C270-0713
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C270-0713 available by request